Amelioration of sepsis by TIE2 activation–induced vascular protection
- 20 April 2016
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 8 (335) , 335ra55
Abstract
Vascular protection through TIE2 activation is a potential treatment strategy to ameliorate sepsis.Keywords
Funding Information
- Samsung Advanced Institute of Technology
- Institute for Basic Science (IBS-R025-D1)
- Ministry of Science, ICT & Future Planning
This publication has 70 references indexed in Scilit:
- The TLR4 antagonist Eritoran protects mice from lethal influenza infectionNature, 2013
- Impaired function of the Tie-2 receptor contributes to vascular leakage and lethality in anthraxProceedings of the National Academy of Sciences, 2012
- Into the Eye of the Cytokine StormMicrobiology and Molecular Biology Reviews, 2012
- Effects of Angiopoietin-2-Blocking Antibody on Endothelial Cell–Cell Junctions and Lung MetastasisJNCI: Journal of the National Cancer Institute, 2012
- Stabilized imaging of immune surveillance in the mouse lungNature Methods, 2010
- Critical care and the global burden of critical illness in adultsThe Lancet, 2010
- Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and InfluenzaScience Translational Medicine, 2010
- Angiopoietin-1 alters microvascular permeability coefficients in vivo via modification of endothelial glycocalyxCardiovascular Research, 2009
- Immunodesign of experimental sepsis by cecal ligation and punctureNature Protocols, 2008
- Endotoxemia and sepsis mortality reduction by non-anticoagulant–activated protein CJournal of Experimental Medicine, 2007